Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001863599 | SCV002108811 | pathogenic | not provided | 2021-07-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with ELP1-related conditions. This variant is present in population databases (rs769748960, ExAC 0.001%). This sequence change creates a premature translational stop signal (p.Thr1128Profs*12) in the ELP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ELP1 are known to be pathogenic (PMID: 18303054, 24173031). |
Fulgent Genetics, |
RCV002503378 | SCV002806917 | likely pathogenic | Medulloblastoma; Familial dysautonomia | 2022-05-12 | criteria provided, single submitter | clinical testing |